STOCK TITAN

Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Clovis Oncology (Nasdaq: CLVS) announced that President and CEO Patrick J. Mahaffy will present at the BofA Securities 2022 Healthcare Conference on May 11, 2022, at 10:00 a.m. Pacific time. The event will take place at the Encore hotel in Las Vegas.

A live webcast of the presentation will be accessible via the company’s investor relations page, with a replay available for 30 days post-event. Clovis Oncology focuses on developing innovative anti-cancer agents and diagnostic tools aimed at specific cancer populations.

Positive
  • None.
Negative
  • None.

BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 10:00 a.m. Pacific time. The conference will be held at the Encore hotel in Las Vegas.

A live webcast of the presentation can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the US, Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the US and Europe.

Anna Sussman

(303) 625-5022

asussman@clovisoncology.com

Breanna Burkart

(303) 625-5023

bburkart@clovisoncology.com

Source: Clovis Oncology, Inc.

FAQ

When will Clovis Oncology present at the BofA Securities 2022 Healthcare Conference?

Clovis Oncology will present on May 11, 2022, at 10:00 a.m. Pacific time.

Where is the BofA Securities 2022 Healthcare Conference held?

The conference is held at the Encore hotel in Las Vegas.

How can I access the Clovis Oncology presentation?

The presentation can be accessed through the investor relations section of Clovis Oncology's website.

Will there be a replay of Clovis Oncology's presentation available?

Yes, a replay will be available for 30 days after the live presentation.

What is the focus of Clovis Oncology as a company?

Clovis Oncology focuses on acquiring, developing, and commercializing innovative anti-cancer agents.

CLVS

NASDAQ:CLVS

CLVS Rankings

CLVS Latest News

CLVS Stock Data

11.77M
142.86M
1.44%
25.9%
19.65%
Biotechnology
Healthcare
Link
United States
Boulder